A Prospective, Phase Ii Trial Of Low-Dose Afatinib Monotherapy For Patients With Egfr, Mutation-Positive, Non-Small Cell Lung Cancer (Torg1632) R. Noro,S. Igawa,A. Bessho,T. Hirose,S. Tsuneo,M. Nakashima,K. Minato,N. Seki,T. Tokito,T. Harada,S. Sasada,S. Miyamoto,Y. Tanaka,N. Furuya,T. Kaburagi,H. Hayashi, H. Iihara,K. Naoki,H. Okamoto,K. KubotaAnnals of Oncology（2020）引用 0|浏览48暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
